Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0949 USD | +5.44% | +20.43% | -53.48% |
03-26 | Transcript : NovaBay Pharmaceuticals, Inc., Q4 2023 Earnings Call, Mar 26, 2024 | |
03-26 | NovaBay Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Evolution of the average Target Price on NovaBay Pharmaceuticals
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering NovaBay Pharmaceuticals
Ladenburg Thalmann |
EPS Revisions
- Stock Market
- Equities
- NBY Stock
- Consensus NovaBay Pharmaceuticals